Division of Acute Care Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
J Trauma Acute Care Surg. 2013 Aug;75(2 Suppl 2):S238-46. doi: 10.1097/TA.0b013e31829a8c71.
Damage-control resuscitation (DCR) has been advocated to reduce mortality in military and civilian settings. However, DCR and excessive crystalloid resuscitation may be associated with a higher incidence of acute respiratory distress syndrome (ARDS). We sought to examine the impact of resuscitation strategies on ARDS development in combat casualty care.
A retrospective review of Joint Theater Trauma Registry data on US combat casualties who received at least 1 U of blood product within the first 24 hours of care was performed, cross-referenced with the cohort receiving mechanical ventilation (n = 1,475). Massive transfusion (MT, ≥10 red blood cells [RBCs] and/or whole blood in 24 hours) and volume/ratios of plasma/RBC, platelet/RBC, and crystalloid/RBC (C/RBC, crystalloid liters/RBC units) were examined using bivariate/multivariate logistic regression and local regression analyses as ARDS risk factors, controlling for age, injury severity, admission systolic blood pressure, and Glasgow Coma Scale (GCS) score.
ARDS was identified in 95 cases (6.4%). MT was required in 550 (37.3%) of the analysis cohort. ARDS was more common in MT (46 of 550, 8.4%) versus no-MT cohort (49 of 925, 5.3%), but mortality was not different (17.4% MT vs. 16.3% no-MT). ARDS patients received significantly increased crystalloid of blood product volumes. Increased crystalloid resuscitation (C/RBC ratio > 1.5) occurred in 479 (32.7%) of 1,464 patients. Unadjusted mortality was significantly increased in the cohort with C/RBC ratio of 1.5 or less compared with those with greater than 1.5 (19.1% vs. 6.3%, p < 0.0001), but no difference in ARDS (6.5% vs. 6.6%) was identified. Platelet/RBC ratio did not impact on ARDS. Increasing plasma (odds ratio, 1.07; p = 0.0062) and crystalloid (odds ratio, 1.04; p = 0.041) volumes were confirmed as independent ARDS risk factors.
In modern combat casualty care, increased plasma and crystalloid infusion were identified as independent risk factors for ARDS. These findings support a practice of decreased plasma/crystalloid transfusion in trauma resuscitation once hemorrhage control is established to achieve the mortality benefit of DCR and ARDS prevention.
损伤控制性复苏(DCR)已被提倡用于降低军事和民用环境中的死亡率。然而,DCR 和过度的晶体液复苏可能与急性呼吸窘迫综合征(ARDS)的发生率增加有关。我们试图研究复苏策略对战斗伤员救治中 ARDS 发展的影响。
对接受至少 1 单位血液制品的美国战斗伤员的联合战区创伤登记处数据进行回顾性分析,同时与接受机械通气的队列进行交叉参考(n=1475)。大量输血(MT,24 小时内输注≥10 个红细胞[RBC]和/或全血)和血浆/RBC、血小板/RBC、晶体液/RBC 的比值(C/RBC,晶体液升/RBC 单位)使用双变量/多变量逻辑回归和局部回归分析作为 ARDS 的危险因素,控制年龄、损伤严重程度、入院时收缩压和格拉斯哥昏迷评分(GCS)。
在 95 例(6.4%)中发现 ARDS。在分析队列中,有 550 例(37.3%)需要 MT。MT 组(46/550,8.4%)比非-MT 组(49/925,5.3%)更常见 ARDS,但死亡率没有差异(17.4% MT 与 16.3%非-MT)。ARDS 患者接受了明显增加的晶体液和血液制品的容量。在 1464 例患者中,有 479 例(32.7%)的晶体液/RBC 比值增加。未校正的死亡率在 C/RBC 比值为 1.5 或以下的患者中显著高于 C/RBC 比值大于 1.5 的患者(19.1%比 6.3%,p<0.0001),但 ARDS 无差异(6.5%比 6.6%)。血小板/RBC 比值对 ARDS 无影响。增加的血浆(优势比,1.07;p=0.0062)和晶体液(优势比,1.04;p=0.041)量被确认为 ARDS 的独立危险因素。
在现代战斗伤员救治中,增加的血浆和晶体液输注被确定为 ARDS 的独立危险因素。这些发现支持在控制出血后减少创伤复苏中的血浆/晶体液输注的做法,以实现 DCR 的死亡率获益和预防 ARDS。